BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27869268)

  • 1. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation.
    He D; Zhang W; Deng H; Huo S; Wang YF; Gong N; Deng L; Liang XJ; Dong A
    Chem Commun (Camb); 2016 Dec; 52(98):14145-14148. PubMed ID: 27869268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
    Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
    Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy.
    Li Y; Kang T; Wu Y; Chen Y; Zhu J; Gou M
    Chem Commun (Camb); 2018 Feb; 54(16):1996-1999. PubMed ID: 29411840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
    Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and activity of a folate peptide camptothecin prodrug.
    Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular GSH-activated galactoside photosensitizers for targeted photodynamic therapy and chemotherapy.
    Wang C; Liu L; Cao H; Zhang W
    Biomater Sci; 2017 Jan; 5(2):274-284. PubMed ID: 27942618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A series of camptothecin prodrugs exhibit HDAC inhibition activity.
    Zhu Q; Yu X; Shen Q; Zhang Q; Su M; Zhou Y; Li J; Chen Y; Lu W
    Bioorg Med Chem; 2018 Sep; 26(16):4706-4715. PubMed ID: 30115492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
    Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
    Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
    Leu YL; Chen CS; Wu YJ; Chern JW
    J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo.
    Cheng Z; Huang Y; Shen Q; Zhao Y; Wang L; Yu J; Lu W
    Eur J Med Chem; 2021 Dec; 226():113851. PubMed ID: 34547508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
    Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
    Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
    Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
    Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents.
    Zi CT; Yang L; Xu FQ; Dong FW; Ma RJ; Li Y; Zhou J; Ding ZT; Jiang ZH; Hu JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):234-237. PubMed ID: 30509782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
    Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
    J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy.
    Li Y; Yang H; Yao J; Yu H; Chen X; Zhang P; Xiao C
    Colloids Surf B Biointerfaces; 2018 Sep; 169():273-279. PubMed ID: 29787951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological studies of the thiols-triggered anticancer prodrug for a more effective cancer therapy.
    Xu Y; Chen J; Li Y; Peng S; Gu X; Sun M; Gao K; Fang J
    Org Biomol Chem; 2015 Mar; 13(9):2634-9. PubMed ID: 25581090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.